MAM
Mankind Pharma launches Docflix, an OTT platform for doctors
Mumbai: The leading pharmaceutical company Mankind Pharma has announced the launch of Docflix, an OTT platform only for doctors. Along with building scientific content through the expert team of doctors, Mankind Pharma has also hired the National Institute of Design pass-outs team to ensure the best representation of data and figures, directors and scriptwriters who can weave science into a story to deliver the message in a fun and engaging way.
With the launch of Docflix, the company is committed to bringing world-class content and technology to Indian doctors under the parent umbrella of Mankind Pharma. The new vertical will add to the commitment of the company to “serving life” and ensure to put knowledge first for Indian doctors.
The platform will have twenty different shows on varied subjects, a few shows include Science simplified, Legend inside the white coat, Stitch in time, Cardio Unflip, Digital for doctors, Medico legal Cases in India and Vantage point.
On the technology side, the team is building an AI-enabled personalized interface to deliver individual experiences on the platform. Technological innovations are aimed to deliver convenience to consume content.
Leading expert doctors in cardiovascular space have already partnered with Mankind to build reliable and authentic content that helps doctors in taking clinical decisions faster and thereby aid in reducing cardiovascular mortality rate in the country, which have become the leading cause of mortality in India.
There are several platforms for Doctors to deliver routine content, however, with changing times content delivery formats have become redundant and repetitive. Also, doctors have limited time in our country considering the large gap of doctor to patient ratio. Considering, this Mankind pharma is taking conscious steps to deliver engaging scientific content created by doctors specialised in their fields, in short, and video formats.
Announcing the launch, Mankind Pharma senior president India business Sanjay Koul said, “We are happy to announce our launch in the Digital HCP engagement space with Docflix. It is a new age OTT platform with a wide range of scientific content tailored to various practice needs of Doctors. Design, Story and Convenience are three strong pillars of the platform that will deliver unique, authentic and reliable scientific content.”
Mankind Pharma president of India speciality business Atish Majumdar said, “One of the greatest disruptions that the pandemic has caused is the way we, as humans, have perceived learning.”
“Docflix is but a manifestation of Mankind’s understanding of the new definition of learning and is meant to be a platform that will not only present the best of medical science but also delve into the art behind the science. With Docflix, we at Mankind envision a new age global knowledge platform that will be a humble partner in the learning journey of all our doctors. The platform is launched by the newly set up digital team at Mankind under the guidance of head of digital Rinkesh Shah. The new team brings in a plethora of experience in the HCP engagement space and has overseen the growth of the doctor platforms space in India and Asia in the last decade. The team is uniquely equipped to deliver on the promise.”
On this, Rinkesh Shah said, “It’s important that scientific content is simplified and made interesting for doctors to consume in a short time. The need for continuous education for doctors is very high and thus we at Mankind are committed to making this journey of doctors convenient and engaging. We aim to offer an uncompromised world-class quality experience with reliable scientific content from Indian and global experts and a platform enabled with the latest technology in the OTT space.”
Brands
Tessolve lands a semiconductor veteran to drive its next big push
Ravi Kumar Chirugudu, who started his career at ISRO and has spent 35 years building chips and companies, joins the Bengaluru-based firm as president and chief operating officer
BENGALURU: Tessolve has never been shy about its ambitions. The Bengaluru-based engineering services firm already counts 18 of the world’s top 20 semiconductor companies among its clients, employs more than 3,500 engineers across 12 countries, and last year pocketed a $150m investment from TPG. Now it has hired the executive it believes can turn those assets into something bigger. Ravi Kumar Chirugudu, a 35-year semiconductor veteran who once built satellite payloads for ISRO and has since scaled engineering organisations across three continents, joins as president and chief operating officer, effective immediately.
THE MAN AND THE MANDATE
The appointment is, by any measure, a serious hire. Ravi Kumar Chirugudu comes to Tessolve after senior leadership stints at HCL Technologies, Altran and Wipro, where he managed large profit-and-loss portfolios and oversaw cross-regional teams. Over the course of his career, he has been instrumental in bringing more than 1,000 new products to market across the high-tech, energy and manufacturing verticals. Before the private sector claimed him, he began his working life as a scientist at the Indian Space Research Organisation, contributing to research and development in charge-coupled device technology and satellite payloads, a foundation that shaped everything that followed.
In his new role, he will lead Tessolve’s global growth strategy: expanding its engineering capabilities, deepening customer relationships and accelerating innovation across semiconductor and high-performance computing domains. The brief is broad, but the context is specific. Tessolve operates in the $550 billion global semiconductor market, and its recent moves, the acquisition of Germany’s Dream Chip Technologies and the TPG funding round, have sharpened both its reach and its expectations.
Srini Chinamilli, co-founder and chief executive of Tessolve, is characteristically direct about why Ravi Kumar Chirugudu was the choice:
“As we scale our global semiconductor and system engineering capabilities, Ravi’s appointment marks an important step forward. As global semiconductor demand continues to accelerate across industries, it is creating significant opportunities across the semiconductor lifecycle, from design, packaging, validation and systems integration. Ravi’s deep knowledge and leadership in this ecosystem brings the right mix of industry expertise, customer connect and execution capability, which will play a key role in strengthening our position as a trusted global engineering partner and reinforcing our market leadership.”
THE NEW ARRIVAL SPEAKS
Ravi Kumar Chirugudu, for his part, frames the move in terms of timing and culture, two factors that veteran executives tend to weigh as heavily as title or compensation:
“I am happy to join Tessolve at a time when the industry is rapidly evolving towards more complex, AI-driven systems. What stands out to me is its strong people-first culture and its commitment to bringing value to its customers. The strength of its global team, combined with its deep expertise in semiconductor innovation and next-generation product engineering, creates a solid foundation to build differentiated, scalable solutions. I look forward to working closely with the team to drive strategic growth and strengthen its role in shaping the global semiconductor ecosystem.”
The reference to AI-driven systems is not incidental. The semiconductor industry is in the midst of a structural reshaping, driven by the insatiable compute demands of artificial intelligence. For engineering services firms like Tessolve, which offers end-to-end capabilities from silicon design to packaged parts and invests in high-performance computing, high-speed interfaces, photonics and 5G, the moment is both an opportunity and a test. The company says it is well positioned to capture the next wave of industry growth. Ravi Kumar Chirugudu is now the person who has to prove it.
He came in from outer space, literally, and spent three decades learning how the semiconductor industry works from the inside out. Now Tessolve is betting that accumulated knowledge can help it cross the next frontier. In the $550 billion global chip market, the gap between ambition and execution is measured in engineering hours and leadership quality. Tessolve has just gone shopping for both.
